Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
The Lancet regional health. Europe（2023）
摘要
AstraZeneca.
更多查看译文
关键词
AZD1222,COVID-19,COVIDRIVE,Durability,European,Hospitalisation,Meta-regression,Vaccine effectiveness
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要